1,532
Views
14
CrossRef citations to date
0
Altmetric
Research Paper

MicroRNA-17-5p inhibits thyroid cancer progression by suppressing Early growth response 2 (EGR2)

, , , &
Pages 2713-2722 | Received 05 Mar 2021, Accepted 22 May 2021, Published online: 15 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Linhui Wang, Weiming Weng, Shuhui Yang, Shasha Yang & Richang Du. (2022) Circle RNA circ_0007331 promotes colorectal carcinoma by targeting miR-205-5p/high-mobility group A2 axis. Bioengineered 13:4, pages 9312-9321.
Read now
Tong Sha, Jia Li, Shiqun Sun, Jianing Li, Xuetao Zhao, Zehua Li & Zhi Cui. (2021) YEATS domain-containing 2 (YEATS2), targeted by microRNA miR-378a-5p, regulates growth and metastasis in head and neck squamous cell carcinoma. Bioengineered 12:1, pages 7286-7296.
Read now
Xiurong Lu, Xiao Song, Xiaohui Hao, Xiaoyu Liu, Xianyu Zhang, Na Yuan, Huan Ma & Zhilin Zhang. (2021) miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway. Bioengineered 12:1, pages 7079-7092.
Read now

Articles from other publishers (8)

Zhongqin Gong, Lingbin Xue, Huangcan Li, Simiao Fan, Charles Andrew van Hasselt, Dongcai Li, Xianhai Zeng, Michael Chi Fai Tong & George Gong Chen. (2024) Targeting Nrf2 to treat thyroid cancer. Biomedicine & Pharmacotherapy 173, pages 116324.
Crossref
Junyan Liu, Xin Miao, Jing Yao, Zheng Wan, Xiaodong Yang & Wen Tian. (2024) Investigating the clinical role and prognostic value of genes related to insulin-like growth factor signaling pathway in thyroid cancer. Aging.
Crossref
Jizong Zhang, Guanghui Ren, Tao Huang, Yiming Sang, Yan Zhong & Yongxiang Yi. (2024) miRNA-363-3p Hinders Proliferation, Migration, Invasion and Autophagy of Thyroid Cancer Cells by Controlling SYT1 Transcription to affect NF-κB. Endocrine, Metabolic & Immune Disorders - Drug Targets 24:1, pages 153-162.
Crossref
Guoli Feng, Changju Chen & Yi Luo. (2023) PRMT1 accelerates cell proliferation, migration, and tumor growth by upregulating ZEB1/H4R3me2as in thyroid carcinoma. Oncology Reports 50:6.
Crossref
Yiting Li, Shinong Gu, Xuanwen LiQing Huang. (2023) To identify biomarkers associated with the transfer of diabetes combined with cancer in human genes using bioinformatics analysis. Medicine 102:37, pages e35080.
Crossref
Ahmed S. Doghish, Hesham A. El-Mahdy, Ahmed Ismail, Maghawry Hegazy, Mahmoud Mohamed Mokhtar, Samy Y. Elkhawaga, Mohamed A. Elkady, Amr Mohamed Yehia & Elsayed G.E. Elsakka. (2023) Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways. Pathology - Research and Practice 243, pages 154371.
Crossref
Ana Kober Leite, Kelly Cristina Saito, Thérèse Rachell Theodoro, Fátima Solange Pasini, Luana Perrone Camilo, Carlos Augusto Rossetti, Beatriz Godoi Cavalheiro, Venâncio Avancini Ferreira Alves, Luiz Paulo Kowalski, Maria Aparecida Silva Pinhal, Edna Teruko Kimura & Leandro Luongo Matos. (2023) Profile of MicroRNAs Associated with Death Due to Disease Progression in Metastatic Papillary Thyroid Carcinoma Patients. Cancers 15:3, pages 869.
Crossref
Rui Huang, Hao Yu & Xiao Zhong. (2021) Identification of Novel CircRNA-miRNA-mRNA Regulatory Network and Its Prognostic Prediction in Breast Cancer. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-14.
Crossref